Key result
COVID-19 linked to ~28% higher readmission risk and increased long-term mortality in HF patients.
Why the study?
Patients with pre-existing HF are particularly vulnerable to adverse outcomes following COVID-19, and understanding their long-term cardiovascular sequelae is essential to improve post-infection management and outcomes.
Does COVID-19 infection worsen long-term cardiovascular outcomes in adults with pre-existing heart failure?
Does COVID-19 infection worsen long-term cardiovascular outcomes in adults with pre-existing heart failure?
COVID-19 infection in patients with pre-existing heart failure is associated with a substantial long-term cardiovascular burden, including high rates of readmission and mortality, which are partially mitigated by vaccination.
No takes yet. Share an insight, caveat, or question.
Supports intensified post-COVID surveillance and vaccination in HF patients; confirms sustained readmission and mortality risks.
Parizad et al. (2026) studied this question. COVID-19 increased hospital readmissions by 28% and mortality by 18% at ≥ 12 months in patients with pre-existing heart failure.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: